TY - JOUR
AU - Nurmi, Visa
AU - Mayne, Richard
AU - Knight, Chanice
AU - Almonacid-Mendoza, Hannia L
AU - Secret, Shannah
AU - Estcourt, Lise J.
AU - Hepojoki, Jussi
AU - Šuštić, Tonći
AU - Lamikanra, Abigail A
AU - Tsang, Hoi Pat
AU - Menon, David K
AU - Shankar-Hari, Manu; id_orcid 0000-0002-5338-2538
AU - van der Schoot, C Ellen
AU - Vidarsson, Gestur
AU - Roberts, David J
AU - Simmonds, Peter
AU - Hedman, Klaus
AU - Harvala, Heli
PY - 2025
DA - February
TI - Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial
JO - Journal of Infection
VL - 90
DO - https://doi.org/10.1016/j.jinf.2025.106412
AB - OBJECTIVES: Convalescent plasma (CP) treatment of COVID-19 has shown significant therapeutic effect only when administered early. We investigated the importance of patient and CP seroprofiles on treatment outcome in REMAP-CAP CP trial.
PB - Elsevier
UR - https://www.research.ed.ac.uk/en/publications/individual-patient-and-donor-seroprofiles-in-convalescent-plasma-/
KW - Coronavirus (COVID-19)
ER